These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7822580)

  • 21. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication.
    Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method of recording: a neglected factor in the controversy over the bimodality of electrodermal responsiveness in schizophrenic samples.
    O'Gorman JG
    Schizophr Bull; 1978; 4(2):150-2. PubMed ID: 746365
    [No Abstract]   [Full Text] [Related]  

  • 23. Spectrum diagnosis and ego strength functioning as related to electrodermal activity in a conditioning paradigm.
    Robinson TN; Rosenthal D; Rasmussen PV
    J Psychiatr Res; 1977; 13(4):257-71. PubMed ID: 606809
    [No Abstract]   [Full Text] [Related]  

  • 24. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrodermal anomalies in recent-onset schizophrenia: relationships to symptoms and prognosis.
    Dawson ME; Nuechterlein KH; Schell AM
    Schizophr Bull; 1992; 18(2):295-311. PubMed ID: 1621075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of stimulus significance on the electrodermal response in chronic schizophrenia.
    Bernstein AS; Schneider SJ; Juni S; Pope AT; Starkey PW
    J Abnorm Psychol; 1980 Feb; 89(1):93-7. PubMed ID: 7365121
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrodermal activity as a predictor of schizophrenic relapse.
    Tarrier N; Barrowclough C
    Psychopathology; 1989; 22(6):320-4. PubMed ID: 2639381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects.
    Schell AM; Dawson ME; Nuechterlein KH; Subotnik KL; Ventura J
    Psychophysiology; 2002 Mar; 39(2):124-32. PubMed ID: 12212661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous fluctuations of electrical skin conductance and the actual clinical state in schizophrenics.
    Olbrich R; Mussgay L
    Psychopathology; 1987; 20(1):18-22. PubMed ID: 3628672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study.
    Rossi A; Galderisi S; Rocca P; Bertolino A; Mucci A; Rucci P; Gibertoni D; Aguglia E; Amore M; Andriola I; Bellomo A; Biondi M; Callista G; Comparelli A; Dell'Osso L; Di Giannantonio M; Fagiolini A; Marchesi C; Monteleone P; Montemagni C; Niolu C; Piegari G; Pinna F; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):285-294. PubMed ID: 27381016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bimodal electrodermal activity in schizophrenia.
    Mirkin AM
    Br J Clin Psychol; 1985 May; 24 ( Pt 2)():131-2. PubMed ID: 4005471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychophysiological dysfunctions in the developmental course of schizophrenic disorders.
    Dawson ME; Nuechterlein KH
    Schizophr Bull; 1984; 10(2):204-32. PubMed ID: 6729410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
    Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
    Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrodermal recovery data on children of schizophrenic parents.
    Erlenmeyer-Kimling L; Friedman D; Cornblatt B; Jacobsen R
    Psychiatry Res; 1985 Feb; 14(2):149-61. PubMed ID: 3857654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrodermal and heart-rate measurements in chronic and partially remitted schizophrenic patients.
    Tarrier N; Cooke EC; Lader MH
    Acta Psychiatr Scand; 1978 May; 57(5):369-76. PubMed ID: 676780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.
    Breier A; Schreiber JL; Dyer J; Pickar D
    Arch Gen Psychiatry; 1991 Mar; 48(3):239-46. PubMed ID: 1671741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.